BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei S, Ma W, Zhang B, Li W. NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity. Front Cell Dev Biol 2021;9:634607. [PMID: 33912556 DOI: 10.3389/fcell.2021.634607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wei S, Xiao Z, Huang J, Peng Z, Zhang B, Li W. Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury. International Immunopharmacology 2022;105:108545. [DOI: 10.1016/j.intimp.2022.108545] [Reference Citation Analysis]
2 Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, Rimondi E. Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity. Int J Mol Sci 2021;22:11241. [PMID: 34681901 DOI: 10.3390/ijms222011241] [Reference Citation Analysis]
3 Wang B, Guo H, Qiao Q, Huang Q, Yang P, Song C, Song M, Wang Z, Li Y, Miao Y, Zhao J. Hypervirulent FAdV-4 infection induces activation of the NLRP3 inflammasome in chicken macrophages. Poult Sci 2021;101:101695. [PMID: 35077922 DOI: 10.1016/j.psj.2021.101695] [Reference Citation Analysis]